Favourites   Have ideas?  Sign in / Register

Positive:   Pharmaceutical  ↓4.9   Disease: Acute ischemic stroke (AIS) ↓1.36   Biopharma ↓1.36 «See more»   Disease: Liver ↑4.52   Skin ↑4.52   Dermatology ↑4.52


Disease: Kidney segment

AKBA Akebia Therapeutics, Inc. - Common Stock -5.08% up -8.54% 3.46 + Medicine, Disease: Kidney

Last highlighted: #AKBA SEC report: Akebia Therapeutics, Inc. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Akebia Therapeutics, Inc. -- SEC File Number 211148438
+ My List
CARA Cara Therapeutics, Inc. - Common Stock 4.52% down 7.25% -2.73 + Medicine, Disease: Kidney, Disease: Liver, Skin, Dermatology

Last highlighted: Form 8-K: Regulation FD Disclosure. On April 29, 2021, Cara Therapeutics issued a press release announcing topline.. $CARA https://t.co/cUtiqqrXat
+ My List
DMAC DiaMedica Therapeutics Inc. - Common Stock -1.36% up -7.91% 6.55 + Biopharma, Disease: Kidney, Medicine, Disease: Acute ischemic stroke (AIS)

+ My List
RETA Reata Pharmaceuticals, Inc. - Class A Common Stock -4.9% up -8.35% 3.45 + Pharmaceutical , Disease: Kidney, Medicine

+ My List
RNLX Renalytix AI plc - American Depositary Shares 2.53% 2.53% 0 + Country: Greate Britain, Medicine, Disease: Kidney, Artificial Intelligence

Last highlighted: $RNLX 6-K Renalytix AI (2 Mar, 6:10am) 📰 RenalytixAI Reports Financial Results for Second Quarter of Fiscal Year 2021 https://t.co/XIBCrGVTeh #RNLX #6K #RenalytixAI #News
+ My List

We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.